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MicroRNAs usually interact with 30 noncoding regions
(30NCRs) of target mRNAs leading to downregulation
of mRNA expression. In contrast, liver-specific micro-
RNA miR-122 interacts with the 50 end of the hepatitis
C virus RNA genome, resulting in increased viral RNA
abundance. We find that inserting the viral miR-122
binding site into the 30 noncoding region of a reporter
mRNA leads to downregulation of mRNA expression,
indicating that the location of the miR-122 binding
site dictates its effect on gene regulation. Further-
more, we discovered an adjacent, second miR-122
binding site, separated from the first by a highly con-
served 14-nucleotide sequence. Mutational analysis
demonstrates that both miR-122 binding sites in a
single viral genome are occupied by the microRNA
and function cooperatively to regulate target gene
expression. These findings set a paradigm for dual,
position-dependent functions of tandem microRNA-
binding sites. Targeting an oligomeric microRNA
complex offers potential as an antiviral-intervention
strategy.
INTRODUCTION
MicroRNAs are 21–22 nucleotide RNA molecules that are
expressed in a wide range of eukaryotic organisms (Bartel,
2004; Grimson et al., 2007). Several hundred different human mi-
croRNA genes have been identified, which show considerable
specificity in both tissue type and developmental-stage expres-
sion. Importantly, it has been estimated that each microRNA can
interact with 100 target mRNAs (Brennecke et al., 2005), sug-
gesting that a significant fraction of mRNAs are likely to be reg-
ulated by microRNAs (Lewis et al., 2005; Xie et al., 2005). Animal
microRNAs are thought to function by binding to imperfectly
complementary sites in the 30 noncoding regions (30NCRs) of tar-
get mRNAs and thereby repress mRNA expression. The mecha-
nism by which microRNAs inhibit target mRNA expression is
controversial and likely involves modulation of distinct steps in
translation and mRNA turnover (Jackson and Standart, 2007;
Nilsen, 2007).Hepatitis C virus (HCV) is a hepatotrophic, positive-sense RNA
virus, containing a 9.6 kb genome that establishes persistent
infections, leading to chronic liver disease (Hoofnagle, 2002).
We recently demonstrated that a liver-specific microRNA, miR-
122 (Chang et al., 2004), interacts with sequences in the 50NCR
of HCV RNA and that this interaction is required to maintain
high viral RNA abundance in cultured liver cells (Jopling et al.,
2005). The function of miR-122 is absolutely dependent on an op-
erational microRNA-processing pathway, because siRNA-medi-
ated knockdown of Drosha, DGCR8, Dicer, or each of the four Ar-
gonaute proteins greatly diminished the accumulation of viral
RNA in HCV-infected cells (Randall et al., 2007). Interaction of
miR-122 with the viral genome did not affect rates of translation
and RNA turnover, arguing that rates of viral replication are aug-
mented directly (Jopling et al., 2005). This unprecedented mech-
anism of upregulation of a target mRNA by a microRNA led us to
examine more closely whether the HCV-miR-122 complex is spe-
cialized or whether miR-122 could also mediate upregulation of
a different mRNA. We found that interactions of miR-122 with
the binding site from HCV placed in the 30NCRs of reporter
mRNAs led to downregulation of mRNA expression, arguing
that the location of the miR-122 binding site, the function of the
mRNA, or both, can influence the mechanism by which target
RNA molecules are regulated. Furthermore, we noted a second,
juxtaposed binding site for miR-122 in the HCV genome that is
important to ensure viral RNA accumulation. Genetic comple-
mentation experiments suggested that both sites are simulta-
neously occupied by miR-122 in a single viral mRNA, revealing
a putative novel antiviral target.
RESULTS
The miR-122 Binding Site in HCV Displays
Position-Dependent Function in Gene Expression
when Located in the 50 or 30NCR of Reporter mRNAs
The binding site for miR-122 in the HCV 50 NCRs shows charac-
teristics of a typical miRNA binding site. Specifically, HCV RNA
nucleotides 23–28 display Watson-Crick base-pair complemen-
tarity to the microRNA seed sequence (Lewis et al., 2005) that
encompasses nucleotides 2–7 (Jopling et al., 2005). We have
shown recently that the interaction of miR-122 with the viral ge-
nome is essential for the accumulation of viral RNA in cultured
Huh7 liver cells (Jopling et al., 2005).Cell Host & Microbe 4, 77–85, July 17, 2008 ª2008 Elsevier Inc. 77
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122 binding site is dependent on the surrounding viral-sequence
context and its location at the 50 end of the viral mRNA, we
inserted nucleotides 1–374 of the HCV type 1a genome into
the 50NCR of a firefly luciferase reporter plasmid, designated
pHCV-Luc (Figure 1A). The plasmid was introduced into Huh7
cells together with a control Renilla luciferase-expressing plas-
mid, pRL-SV40. Luciferase activity was measured in the pres-
ence of cotransfected 20O-ribose methylated miR-122 antisense
oligonucleotides (miR-122 antisense) with exact complementar-
ity to miR-122, which were shown to sequester intracellular miR-
122 molecules and to inhibit their activity in the RNA-interfering
pathway (Jopling et al., 2005). Randomized 20O-methylated
RNA oligonucleotides (Random-20OMe), known to have no effect
on miR-122 activity (Jopling et al., 2005), served as negative con-
trols. The data in Figure 1B show that the intracellular abundance
of miR-122 had no effect on the efficiency of reporter-mRNA
expression. Similarly, reporter-gene expression was not affected
after ectopic expression of synthetic wild-type miR-122
molecules (miR-122 wt) (Figure 1B). Control Renilla luciferase ac-
tivities were similar in each of these experiments (data not
shown). These data argue that miR-122 binding sites do not af-
fect the efficiency with which the HCV internal-ribosome entry
site directs protein synthesis when located at the 50 end of
reporter mRNAs.
To examine whether miR-122 affects reporter gene expression
from miR-122 binding sites in 30NCRs, HCV sequences 1–45
were inserted into the 30NCR of the firefly luciferase reporter
gene to yield plasmid pLUC-122x1 (Figure 2A). Luciferase activity
Figure 1. Expression of Reporter mRNAs Containing the
HCV 50 Terminal Sequences in their 50 Noncoding
Sequences
(A) Diagram of capped Renilla luciferase-encoding reporter mRNA
(expressed from plasmid pRL-SV40) and of firefly luciferase-
encoding reporter mRNA (expressed from plasmid pHCV-LUC),
which harbors HCV sequences 1–374 in its 50 NCRs. The nucleo-
tides comprising the HCV 50 noncoding region are shown in bold.
(B) Effects of methylated antisense miR-122 oligos (miR-122 anti-
sense), methylated random (Random-20OMe), or ectopically
expressed wild-type (miR-122 wt) molecules on reporter-mRNA
expression. Firefly luciferase and control Renilla luciferase activi-
ties were measured in lysates, and results from triplicate experi-
ments are displayed as a ratio of firefly:Renilla luciferase activity,
expressed as a percentage of the values obtained from mock-
treated cells. The error bars represent standard error of the
mean. The expression of Renilla luciferase did not vary signifi-
cantly between samples.
was measured in the presence of cotransfected
Random-20OMe oligonucleotides and set as 100
(Figure 2C). Addition of miR-122 antisense oligonucle-
otides enhanced firefly luciferase activity by approxi-
mately 30% (Figure 2C). In contrast, ectopic expres-
sion of synthetic miR-122 wt molecules (Figure 2B)
led to a 50% decrease in luciferase activity (Figure 2C).
Ectopic expression of mutated miR-122p3-4 RNAs
(Figure 2B), which should not bind to wild-type miR-
122 seed-match sequences (Jopling et al., 2005), had
no effect on reporter-mRNA expression (Figure 2C).
Thus, it appears that although the miR-122 binding site in HCV
upregulates gene expression when residing in the 50NCR of a rep-
lication-competent viral genome, it downregulates gene expres-
sion when located in the 30NCR of a reporter mRNA, reminiscent
of the outcome of a typical microRNA-mRNA interaction.
Identification of a Second, Adjacent MicroRNA Binding
Site in the HCV Genome
To determine whether additional miR-122 binding sites
increased the effect on reporter-gene expression, a second
copy of HCV sequence 1–45 was inserted in the 30NCR of
pLUC-122x1, resulting in the plasmid pLUC-122x2 (Figure 3A).
As shown in the black bars in Figure 3B, sequestration of miR-
122 by miR-122 antisense oligonucleotides resulted in an 80%
increase in firefly luciferase activity compared to Random-
20OMe oligonucleotides. In contrast, ectopic expression of syn-
thetic, wild-type miR-122 molecules caused a 70% decrease in
luciferase production compared to mutant miR-122 p3-4 oligo-
nucleotides (Figure 3B). These findings indicate that miR-122-
mediated repression of target mRNAs can occur by binding
of miR-122 to tandem target sites and that the repression is
greater than that mediated by a single target site.
To examine whether luciferase production in the chimeric
mRNAs was modulated by direct binding of miR-122 to the tan-
dem miR-122 binding sites, as opposed to binding to target
sequences located in other mRNAs, the seed-match sequences
in both of the sites in pLUC-122x2 were mutated. Specifically,
the nucleotides at positions 3 and 4 of each seed-match se-
quence were mutated to their complement (i.e., U26C to A26G78 Cell Host & Microbe 4, 77–85, July 17 2008 ª2008 Elsevier Inc.
Cell Host & Microbe
Dual Functions for miR-122-Binding SitesFigure 2. Expression of Reporter mRNAs Containing miR-122-
Binding Sites in their 30NCRs
(A) Diagram of capped Renilla luciferase-encoding reporter mRNA (expressed
from plasmid pRL-SV40) and of firefly luciferase-encoding reporter mRNA
(expressed from plasmid pLUC-122x1), which harbors HCV sequences 1–45
in its 30 NCR. The nucleotides comprising the miR-122 seed-match sequence
in the viral RNA are shown in bold.
(B) Nucleotide sequences of ectopically expressed wild-type miR-122 (miR-
122 wt) and of a mutant miR-122 that contains mutations at positions 3 and
4 in the seed match (miR-122 p3-4).
(C) Effects of methylated random (Random-20OMe), methylated antisense
miR-122 oligos (miR-122 antisense), ectopically expressed wild-type (miR-
122 wt), or mutant (miR-122 p3-4) miR-122 molecules on reporter-mRNA
expression. Firefly luciferase and control Renilla luciferase activities were mea-
sured in lysates, and results from triplicate experiments are displayed as a ratioto yield S1:p3-4) such that the mutant sites are not predicted to
bind wild-type miR-122 molecules. Instead, they should bind to
mutant miR-122p3-4 molecules, restoring base pairing to the
mRNA-miRNA pair. As shown by the striped bars in Figure 3B,
miR-122 sequestration by methylated antisense miR-122 mole-
cules still displayed an effect on reporter-gene expression, al-
though the effect was reduced relative to the effect observed
with wild-type sequences. Furthermore, ectopic expression of
either wild-type or mutant miR-122p3-4 microRNAs decreased
reporter-gene expression (Figure 3B). These results suggest
that additional binding sites for wild-type miR-122 may be pres-
ent in the reporter mRNAs. Indeed, inspection of HCV nucleotide
sequences 1–45 revealed a potential second seed-match se-
quence that could form a Watson-Crick base-pair interaction
with miR-122. This putative seed-match 2, spanning viral nucle-
otides 38–43, is highlighted in Figure 3A.
To test whether both seed-match 1 and 2 functioned in the first
45 nucleotides of the HCV genome, positions 3 and 4 in both
sequence elements were mutated to their complementary nucle-
otides (i.e., U26C to A26G and U41C to A41G) to yield plasmid
S1+S2:P3-4 (Figure 3A). Results from expression studies with
this plasmid are shown by the white bars in Figure 3B. Neither
sequestration of wild-type miR-122 nor overexpression of wild-
type miR-122 had a significant effect on the expression of this
reporter mRNA. However, ectopic expression of mutant miR-
122p3-4 molecules caused an 80% decrease in luciferase activ-
ity. These findings provide genetic evidence for the presence of
two functional miR-122 binding sites that can downregulate
luciferase production.
Translational Repression Mediated by Tandem miR-122
Binding Sites Located in 30NCRs
There is some controversy about the mechanism by which mi-
croRNA-mediated repression occurs in mammalian cells. Stud-
ies have provided examples for microRNA-mediated repression
at the translation initiation step, at the translation elongation
step, and at the postelongation step. Furthermore, there are
examples of microRNA-mediated mRNA degradation, possibly
occurring as a result of translational repression (reviewed in
Jackson and Standart, 2007 and Nilsen, 2007).
To examine the intracellular abundances of the reporter
mRNAs, total RNA was extracted from Huh7 cells that had
been transfected with plasmid pLUC-122x2 in the presence of
the various small RNA modulators, and reporter mRNA abun-
dances were quantified by real-time quantitative PCR. Whereas
the ratio of firefly:Renilla luciferase activity changed with seques-
tration or overexpression of miR-122 as described above
(Figure 3B, black bars), no significant change in the ratio of
firefly:Renilla mRNA was observed under these conditions
(Figure 3C). These findings argue that miR-122 mediates transla-
tional repression via two seed matches in the HCV genome when
located in the 30NCR of a luciferase mRNA and that this
of firefly:Renilla luciferase activity, expressed as a percentage of the values ob-
tained in cells treated with Random-20OMe. The error bars represent standard
error of the mean. The expression of Renilla luciferase did not vary significantly
between samples.Cell Host & Microbe 4, 77–85, July 17, 2008 ª2008 Elsevier Inc. 79
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involve mRNA degradation.
Regulation of a TandemmiR-122 Binding Site in the HCV
Genome by Cellular miR-122
We have previously shown that mutation of seed-match 1 dimin-
ished HCV RNA accumulation, which can be restored by mutant
miR-122 molecules that can bind to the mutated seed-match se-
quence (Jopling et al., 2005). To examine a functional role for the
seed-match 2 site in modulating HCV gene expression, defined
mutations at the p3 and p4 positions of the seed match
Figure 3. Expression of Reporter mRNAs that Contain
Tandem HCV Sequence Elements
(A) Diagram of a capped firefly luciferase-encoding reporter mRNA,
expressed from plasmid pLUC-122x2, which harbors two HCV
sequence elements in its 30NCR. Shown below are mutations at posi-
tions 3 and 4 of the miR-122 seed match in each copy of the HCV
sequence element (seed-match 1 and 2).
(B) Effects of various oligos and duplex mRNAs on reporter mRNA
expression. See details in legend to Figure 1C.
(C) Effects of various oligos and duplex RNAs on RNA abundance of
reporter RNAs. RNA abundance was measured by quantitative RT-
PCR analysis. Results from triplicate experiments are displayed as
a ratio of firefly:Renilla RNA abundance and are expressed as a per-
centage of the values obtained in cells treated with Random-20OMe.
The error bars represent standard error of the mean.
(Figure 4A) were introduced into a type 1a HCV genome
that contains adaptive mutations that allow it to replicate
in Huh7 cells (Yi et al., 2006). In particular, double muta-
tions (p3-4) in HCV were generated, in which seed
matches 1 (S1) and 2 (S2) were both mutated at the p3
and p4 positions (Figure 4A). RNA abundance of mutant
RNAs was measured after electroporation into Huh7 cells.
The northern blot in Figure 4B (lane 1) shows that signifi-
cant amounts of wild-type HCV RNA could be detected
5 days after electroporation, whereas neither mutant
S2:p3-4 nor S1+S2:p3-4 RNA could be detected in trans-
fected cells (lanes 2 and 4). However, both S2:p3-4 and
S1+S2:p3-4 RNA could be detected after cotransfection
of miR-122p3-4 RNAs, predicted to base pair with the
mutant-HCV genomes (Figure 4B, lanes 3 and 5). Interest-
ingly, ectopic expression of miR-122p3-4 repeatedly
rescued the abundance of HCV RNAs that contained
mutations at both S1 and S2 to near wild-type levels
(Figure 4B, lane 5), suggesting that ectopically expressed
miR-122 RNAs display cooperative effects on HCV gene
expression. Therefore, miR-122 interaction at seed-
match 1 alone is not sufficient to augment HCV-RNA
abundance. We conclude that miR-122 interactions at
both seed matches are required for efficient HCV-RNA
accumulation.
To determine the effects of single-nucleotide mutations
in seed-match 1 and seed-match 2, mutations at the p3
positions of both seed-match sequences were tested.
Similar to the findings with the double mutants, a single
mutation in S2 (Figure 4C, lane 2) or single mutations in
both S1 and S2 (Figure 4C, lane 4) abolished RNA accu-
mulation, which could be restored by cotransfection of
miR-122p3 molecules (Figure 4C, lanes 3 and 5). These findings
also argue that miR-122 binding to seed-match 1 is not sufficient
to allow viral RNA amplification.
To examine whether both seed-match sequences are required
to maintain HCV RNA abundance and are occupied by miR-122
in a single HCV RNA molecule, we introduced distinct mutations
into S1 and S2 and monitored rescue of RNA abundance after
transfection of distinct miR-122 molecules. Specifically, a p3
mutation in S1 and a p3-4 mutation in S2 were generated in
the same viral RNA molecule (Figure 4A). Transfection of this mu-
tant RNA into Huh7 cells did not lead to detectable HCV RNA80 Cell Host & Microbe 4, 77–85, July 17 2008 ª2008 Elsevier Inc.
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Dual Functions for miR-122-Binding SitesFigure 4. Effects of Mutations in Seed-Match Sequences on Abun-
dance of Replication-Competent HCV RNA
(A) Diagram of the introduced mutations in the two viral seed-match
sequences for miR-122.
(B–D) RNA abundances of wild-type or mutant HCV RNAs. Abundances were
measured by northern blot analyses 5 days after electroporation into Huh7accumulation 5 days after electroporation (Figure 4D, lane 2).
Presumably, the endogenous wild-type miR-122 RNA had no ef-
fect on either mutant seed-match sequence. Cotransfection of
either miR-122p3 or miR-122p3-4 molecules was not sufficient
to restore RNA abundance (Figure 4D, lanes 3 and 4). In contrast,
simultaneous transfection of both miR-122 mutant RNAs
restored HCV RNA abundance (Figure 4D, lane 5). This experi-
ment suggests that both miR-122 binding sites need to interact
with miR-122, either sequentially or concurrently, in a single
HCV molecule to ensure viral RNA amplification.
Effect of a miR-122 Seed-Match Substitution on HCV
Gene Expression
Next, we examined whether roles for miR-122 can be substituted
by other microRNAs. Thus, we exchanged the miR-122 seed-
match 1 sequence element in the HCV genome with a seed-
match element that is predicted to base pair with microRNA
miR-21 (Figure 5A). Transfection of the mutant HCV-m21
genome into Huh7 cells failed to accumulate viral RNA
(Figure 5B). While miR-21 is expressed at a 5-fold lower level
than miR-122 in these cells (data not shown), HCV RNA abun-
dance could not be rescued after ectopic expression of miR-
21 duplexes (data not shown). These findings suggest that
oligomeric miR-122 complexes have specialized functions in
HCV replication or that the seed-match substitution affected
sequences whose integrity is essential for viral genome
amplification.
Modulation of Viral Gene Expression by Sequences
Encompassing the Tandem miR-122-Binding Sites,
Including a Conserved 14-Nucleotide Spacer Sequence
Element
To distinguish roles for sequences surrounding the miR-122-
binding sites in microRNA binding or viral RNA replication, the
replication competence of HCV genomes carrying defined muta-
tions was examined. It is known that nucleotide length between
two tandemly located microRNA-binding sites can dictate the
efficiency by which the microRNA regulates target mRNA
expression (Doench and Sharp, 2004; Saetrom et al., 2007).
In particular, optimal downregulation was found to be mediated
by tandem microRNA-binding sites in which the distance from
the start of one seed to the start of the second seed sequence
is 13–35 nucleotides (Saetrom et al., 2007). A 14-nucleotide
distance was observed between S1 and S2 in HCV RNA
(Figure 6A). Together with seed-match sequences 1 and 2, this
spacer sequence element is highly conserved between HCV
genotypes, except that adenosine at position 36 is missing in
genotypes 5 and 6 (Figures 7A and 7B). To examine whether
the conserved linker sequence is important for miR-122-medi-
ated regulation of HCV RNA abundance, conserved nucleotides
C30 and C31 were changed to adenosines (Figure 6A). As shown
in Figure 6B, transfected mutated viral genomes (pCC-AA)
cells. Duplex miR-122p3 or miR-122p3-4 molecules were introduced into cells
1 day prior to electroporation of HCV RNAs and again at 1 and 3 days after
electroporation of viral RNA. Autoradiographs of northern blots, displaying
HCV- and g-actin RNA abundance from an example of triplicate experiments,
are shown.Cell Host & Microbe 4, 77–85, July 17, 2008 ª2008 Elsevier Inc. 81
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genomes (Figure 6B, lanes 2 and 3). Ectopic expression of
miR-122 wt duplexes did not rescue viral RNA abundance.
More dramatically, mutant viral RNAs with nucleotides C30
and C31 deleted (pDCC) failed to accumulate to detectable
levels after transfection into Huh7 cells (Figure 6B, lanes 4 and
5), and abundance could not be rescued by ectopic expression
of miR-122 duplexes. Similarly, insertions of two or four uridines
at position 32 (Figure 6A) into the viral genome failed to generate
significant levels of replication-competent RNAs (Figure 6C,
lanes 3 and 4). Insertion of the pCC-AA substitution, or the
pDCC deletion, into the 30NCR of pLUC-122x1 (Figure 2A)
displayed translational repression in a microRNA-dependent
manner that was similar to pLUC-122x1-derived mRNAs, which
contain wild-type microRNA-binding sites and spacer se-
quences (Figure S1). These findings suggest that the spacer nu-
cleotides contribute to the formation of a replication-competent
Figure 5. Effect of a Seed-Match Substitution on Abundance of
Replication-Competent HCV RNA
(A) Diagram showing the locations of the introduced seed-match swap.
(B) RNA abundances of wild-type or mutant HCV-m21 RNAs after electropo-
ration into Huh7 cells. An autoradiograph of a northern blot is shown. Experi-
mental protocol was performed as described in the legend to Figure 4.82 Cell Host & Microbe 4, 77–85, July 17 2008 ª2008 Elsevier Inc.RNA structure. Alternatively, engagement of the viral miR-122-
binding sites with miR-122 has different effects on viral replica-
tion and reporter mRNA translation.
DISCUSSION
Most or all binding sites for microRNAs have been detected in
30NCRs of target mRNAs (Lewis et al., 2005). Interactions of
one or more microRNAs have been shown to lead to reduced
expression of target mRNAs, and the mechanisms that repress
mRNAs are potentially diverse (Jackson and Standart, 2007;
Lewis et al., 2005). The positive effect of the interaction of miR-
122 with HCV RNA on intracellular RNA abundance was surpris-
ing and raised the question whether a specialized miR-122-pro-
tein complex or the location of the miR-122-binding site at the 50
end of the viral genome dictated its function. Thus, we examined
the functional role of the HCV-miR-122-binding site when
located in the 50 or 30NCRs of a reporter mRNA, which was
expressed by polymerase II. Results showed that reporter
mRNAs, which lacked or contained miR-122-binding sites in
their 50NCRs, were translated with similar efficiencies in cultured
human Huh7 cells. This result is in contrast to the finding of Lytle
et al. (2007), who noted that let7 microRNA-binding sites in
50NCRs diminished translational efficiencies of reporter mRNAs
in human HeLa cells. Because the affinity of microRNAs for tar-
get mRNA sequences is unknown, it is possible that the micro-
RNA species or the composition of the RNA-induced silencing
complex (RISC) can dictate the outcome by which the micro-
RNA-mRNA complex is regulated. However, reporter mRNAs
that contained miR-122 binding sites in their 30NCRs were
repressed at a posttranscriptional step in the presence of miR-
122. This finding suggests that the location of the miR-122-bind-
ing site in an mRNA can dictate its function and that miR-122
does not associate with RISC, which has a specialized upregu-
lating function in liver cells.
miR-122 binds to two adjacent sites in the HCV 50NCR, and
binding to both sites is required to maintain RNA abundance
(Figures 7A and 7C). This finding was surprising because of the
extreme proximity of the sites to each other. However, the 14-nu-
cleotide spacer sequence between the miR-122-binding sites is
highly conserved among HCV genotypes (Figure 7B). For both
sites in the viral genome to be occupied concurrently, this would
preclude base-pair interactions outside the seed-match
sequences (Figure 7C). Results from mutagenesis of the spacer
region suggested that both spacer length and sequence context
are important in allowing efficient accumulation of HCV RNA
in RNA-transfected cells. However, some of the spacer-region
mutants still repressed reporter mRNA translation in a micro-
RNA-dependent manner. This observation argues that the
spacer sequence contains RNA sequences that are essential
for viral RNA replication. Crosslinking experiments, designed to
test whether two miR-122 molecules can bind to spacer-mutant
RNAs, are currently being employed to distinguish between
these possibilities.
While genetic evidence suggested that miR-122 needs to
interact with both seed-match site 1 and seed-match site 2 in
HCV to allow RNA accumulation, it is possible that miR-122
RISC complexes contact only one site, then dissociate and sta-
bly associate with the second site. While such a hit-and-run
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Dual Functions for miR-122-Binding Sitesmechanism is possible, it is more likely that two miR-122 RISCs
are anchored—predominantly by seed-seed-match interac-
tions—simultaneously on the same mRNA molecule. A recent
study has shown that optimal repression of a target mRNA can
be achieved by tandem microRNA-binding sites that are sepa-
rated by 13–35 nucleotides (Saetrom et al., 2007). Because
effects of 30 end sequences in the microRNA were minimized in
this study, it was concluded that optimally spaced seed-seed-
Figure 6. Effects of Mutations in Spacer Sequences on
Abundance of Replication-Competent HCV RNA
(A) Diagram showing the locations of the introduced mutations in the
spacer sequences.
(B and C) RNA abundances of wild-type or mutant HCV RNAs carrying
mutations in the spacer sequence element after electroporation into
Huh7 cells. An autoradiograph of a northern blot showing RNA abun-
dance of wild-type or mutant RNAs is shown. Experimental protocol
was carried out as described in the legend to Figure 4. The ratio of
HCV- to g-actin RNA from three independent experiments is shown
above the autoradiograph. The error bars represent standard error
of the mean.
match microRNA RISCs may cooperatively regulate
gene expression (Saetrom et al., 2007). Similarly, it is pos-
sible that the tandem binding of miR-122 RISC to the HCV
genome provides a RNA-protein scaffold for factors that
enhance viral RNA abundance. Such a scaffold could pro-
vide a novel antiviral target. Studies in mice indicated that
the normal function of miR-122 in liver is to regulate the ex-
pression of genes involved in cholesterol and fatty-acid
biosynthesis (Esau et al., 2006; Kru¨tzfeldt et al., 2005).
Whether mRNAs targeted by miR-122 are regulated by
a similar cooperative mechanism is unknown, but it is
curious that numerous microRNA-targeted mRNAs are
predicted to bind several copies of microRNAs that can
be either identical or distinct (Saetrom et al., 2007).
The observation that the miR-122 RISC-HCV complex
can exert either a positive or negative function on tar-
get-mRNA expression is intriguing. When located in the
30NCR of a reporter mRNA, the miR-122 RISC downregu-
lates mRNA expression, as would be expected for any
microRNA. However, location of the miR-122 RISC com-
plex at the 50 end of the viral genome upregulates viral-
RNA abundance. In this case, translation of the viral ge-
nome is not affected (Jopling et al., 2006; Jopling et al.,
2005). Similarly, inserting the miR-122-binding site into
the 50NCR of a reporter mRNA had no effect on transla-
tional efficiency of the targeted mRNA. Thus, the upregu-
lating function of miR-122 is, thus far, confined to a repli-
cating viral mRNA. The mechanism by which viral RNA
abundance is augmented by miR-122 will most likely in-
volve modulating rates of RNA amplification and, possibly,
intracellular targeting of miR-122 RISC-HCV complexes.
EXPERIMENTAL PROCEDURES
Oligonucleotides and DNA Constructs
RNA oligonucleotides and 20-O-methylated oligonucleotides were
synthesized by Dharmacon, Inc. (Lafayette, CO). The sequences
were 122-20OMe, 50-AGACACAAACACCAUUGUCACACUCCAC
AGC-30; Rand-20OMe, 50-CACGUUAAAACCAUACGCACUACGAAACCCC-
30; miR-122 wt, 50-UGGAGUGUGACAAUGGUGUUUGU-30; miR-122p3, 50-
UGCAGUGUGACAAUGGUGUUUGU-30; miR-122p3-4, 50-UGCUGUGUG
ACAAUGGUGUUUGU-30; and miR-122*, 50-AAACGCCAUUAUCACACUAA
AUA-30. Duplexes were formed between the wt, p3, or p3-4 forms of miR-
122 and its complement (miR-122*).
To generate the plasmid pHCV-LUC, nucleotides 1–374 of HCV type 1a
were amplified by PCR from the vector pH77DE1/p7 (Yi et al., 2006) us-
ing the primers 50-CGACTCAAGCTTGCCAGCCCCCTGATGGGG-30 andCell Host & Microbe 4, 77–85, July 17, 2008 ª2008 Elsevier Inc. 83
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Dual Functions for miR-122-Binding SitesFigure 7. miR-122 Seed-Match Sequences and Predicted Interac-
tions with miR-122
(A) Locations of the miR-122 seed-match sequences (highlighted in red) in
HCV genotype 1a. The nucleotides linking the two seed-match sequences
are highlighted in blue. The conserved 14-nucleotide spacer element is located
between the arrows positioned at nucleotide 1 of seed-match 1 and nucleotide
1 of seed-match 2.
(B) Seed-match sequences (red) and surrounding sequences (blue), which are
conserved in all HCV genotypes, are shown. The missing adenosine nucleotide
36 in HCV type 5 and type 6 is indicated by a ‘‘’’ symbol. Consensus
sequences were compiled with the aid of the HCV-sequence database at
http://hcv.lanl.gov/content/hcv-db/index.84 Cell Host & Microbe 4, 77–85, July 17 2008 ª2008 Elsevier Inc.50-GTTGGTGTTACCCATGGTTTTTCTTTGAGG-30 and inserted between the
HindIII and NcoI restriction sites in the plasmid pGL3con (Promega). To gener-
ate plasmid pGL3-MCS, a multiple cloning-site cassette, 50-GATGAAGCTTAC
TAGTGCGGCCGCTGCAGAATTCCCGGGCCCGCGGATCCATCAGCTAGA-30,
was ligated into the XbaI site in the SV40 promoter-based vector pGL3con
(Promega), allowing insertion of HCV sequences into the 30NCR. Nucleotides
1–45 of the HCV type 1a sequence were amplified by PCR from the vector
pH77DE1/p7 and inserted between the SpeI and EcoRI sites in pGL3-MCS
to create the plasmid pLUC-122x1. The plasmid pLUC-122x2 was con-
structed by PCR amplification and insertion of a second copy of nucleotides
1–45 of HCV, between the EcoRI and SacII sites in pLUC-122x1. The nucleo-
tides that bind to p3-4 of miR-122 in seed-match site 1 in each of the two sites
in pLUC-122x2 were mutated to their complement to create S1:P3-4A: U26C
to A26G. This mutation was also introduced into seed-match site 2 in each of
the two sites to generate S2:P3-4B: U41C to A41G. The p3-4 and p3 seed-
match mutations were created in the vector pH77DE1/p7 by overlap PCR of
the region between the XmnI and KpnI restriction sites, using the outer primers
50-GCTCATCATTGGAAAACGTTCTTCGGGGCG-30 and 50-GCCAAGGGTAC
CCGGGCTGAGCCCAGGTCC-30. The mutagenic primers 50-CCATGAATCAC
AGCCCTGTGAGGAACTAC-30 and 50-GTAGTTCCTCACAGGGCTGTGATT
CATGG-30 were used to generate the S2:p3-4 mutant, and primers 50-CCATG
AATCACTGCCCTGTGAGGAACTAC-30 and 50-GTAGTTCCTCACAGGGCAG
TGATTCATGG-30 to create S2:p3. The S1+S2:p3-4 and S1+S2:p3 mutants
were generated by the same method using the previously published S1:p3-4
and S1:p3 mutants as templates (Jopling et al., 2005). Mutant HCV-m21
was generated by changing nucleotides 23–28 in the HCV genome from
ACAUCC to UAAGCU.
The pCC-AA, pDCC, 32-2xU, and 32-4xU mutations were created by
directed mutagenesis (Quickchange II XL, Stratagene). A PCR fragment
spanning the XmnI and AgeI restriction sites of the pH77DE1/p7 plasmid
(50-TGCTCATCATTGGAAAACG-30, 50-GGCAATTCCGGTGT ACTCAC-30) was
subcloned by TOPO-TA cloning into pCR2.1 (Invitrogen) and mutated accord-
ing to the manufacturer’s instructions with the following primers: pCC-AA:50-
CTGATGGGGGCGACACTCCAAAATGAATCACTCCCCTGTGAG-30 and 50-C
TCACAGGGGAGTGATTCATTTTGGAGTGTCGCCCCCATCAG-30, pDCC:50-C
TGATGGGGGCGACACTCCAATGAATCACTCCCCTGTGAG-30 and 50-CTCA
CAGGGGAGTGATTCATTGGAGTGTCGCCCCCATCAG-30. 32-2xU: 50-CTGA
TGGGGGCGACACTCCACCTTATGAATCACTCCCCTGTGAG-30 and 50-CT
CACAGGGGAGTGATTCATAAGGTGGAGTGTCGCCCCCATCAG-30. 32-4xU:
50-CTGATGGGGGCGACACTCCACCTTTTATGAATCACTCCCCTGTGAG-30
and 50-CTCACAGGGGAGTGATTCATAAAAGGTGGAGTGTCGCCCCCATCA
G-30.The mutated sequences were inserted into the parental vector between
the XmnI and AgeI sites.
Cell Culture and Transfection
Huh7 cells were cultured in DMEM supplemented with 10% FBS and 1% non-
essential amino acids (GIBCO). DNA constructs and oligonucleotides were
introduced into cells in six-well plates using Lipofectamine 2000 (Invitrogen),
according to the manufacturer’s instructions. Theplasmid pRL-SV40 (Promega)
was included as a transfection control. The 20-O-methylated oligonucleotides
and the miR-122 RNA duplexes were delivered to cells at a concentration of
20 nM in the medium. Transfected cells were cultured for 24 hr before harvesting
into Passive Lysis Buffer (Promega), according to the manufacturer’s instruc-
tions. The replication-competent HCV RNA, H77DE1/p7 (Yi et al., 2006), carry-
ing a deletion in the envelope gene, was generated by in vitro transcription using
the T7 Megascript kit (Ambion), according to the manufacturer’s instructions,
and introduced into Huh7 cells by electroporation as described (Yi and Lemon,
2004). RNA was prepared and processed 5 days later. When included in exper-
iments, miR-122 duplexes were introduced by Lipofectamine 2000-mediated
transfection at 1 day prior to electroporation and 1 and 3 days subsequently.
RNA Isolation and Northern Analysis
Total RNA was extracted from cells using Tri Reagent (Sigma), according to the
manufacturer’s instructions. To analyze mRNA levels, 5–20 mg of total RNA
was separated in 1% agarose gels containing 13 MOPS buffer and 2.2 M
(C) Potential interactions of two miR-122 molecules (shown in green) with the
seed-match sequences (red) in HCV are shown.
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Dual Functions for miR-122-Binding Sitesformaldehyde (Ausubel et al., 1989) and transferred to Zeta-probe membrane
(Bio-Rad). The membranes were hybridized overnight in Church-Gilbert solu-
tion (180 mM Na2HPO4, 70 mM NaH2PO4, 7% SDS) to random-primed
32P-la-
beled DNA probes complementary to nucleotides 84–374 of HCV and to nucle-
otides 685–1171 of g-actin, as indicated.
Quantitative Real-Time PCR
Relative amounts of firefly and Renilla luciferase RNA were quantified by real-
time PCR using a Rotor-gene SE6000 (Corbett Life Science). The primers used
were 50-TCGCCAGTCAAGTAACAAC and 50-ACTTCGTCCACAAACACAA to
amplify firefly luciferase RNA and 50-AACGCGGCCTCTTCTTATTT and 50-
GTCTGGTATAATACACCGCG for Renilla luciferase. PCR was carried out us-
ing Power SYBR Green PCR Master Mix (Applied Biosystems) according to the
manufacturer’s instructions.
SUPPLEMENTAL DATA
Supplemental Data include one figure and can be found online at http://www.
cellhostandmicrobe.com/cgi/content/full/4/1/77/DC1/.
ACKNOWLEDGMENTS
We are grateful to Richard Jackson (Cambridge University), in whose labora-
tory many of these experiments were performed. We thank Karla Kirkegaard
for critical comments on the manuscript. We also thank Gus Zeiner for use
of electroporation reagents. Work performed in the authors’ laboratories
was supported by grants from the Wellcome Trust (C.L.J.), the Deutsche For-
schungsgemeinschaft (Schu 22941/2-1 to S.S.), and the National Institutes of
Health (GM069007, AI047365, and AI069000 to P.S.).
Received: March 6, 2008
Revised: May 12, 2008
Accepted: May 18, 2008
Published: July 16, 2008
REFERENCES
Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Smith, J.A., Seidman,
J.G., and Struhl, K. (1989). Current Protocols in Molecular Biology (New
York: Greene Publishing Associates and John Wiley & Sons, Inc.).
Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and func-
tion. Cell 116, 281–297.
Brennecke, J., Stark, A., Russell, R.B., and Cohen, S.M. (2005). Principles of
microRNA-target recognition. PLoS Biol. 3, e85.
Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M.A., Xu, C.,
Mason, W.S., Moloshok, T., Bort, R., et al. (2004). miR-122, a mammalian liver-
specific microRNA, is processed from hcr mRNA and may downregulate the
high affinity cationic amino acid transporter CAT-1. RNA Biol. 1, 106–113.Doench, J.G., and Sharp, P.A. (2004). Specificity of microRNA target selection
in translational repression. Genes Dev. 18, 504–511.
Esau, C., Davis, S., Murray, S.F., Yu, X.X., Pandey, S.K., Pear, M., Watts, L.,
Booten, S.L., Graham, M., McKay, R., et al. (2006). miR-122 regulation of lipid
metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87–98.
Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P., and
Bartel, D.P. (2007). MicroRNA targeting specificity in mammals: determinants
beyond seed pairing. Mol. Cell 27, 91–105.
Hoofnagle, J.H. (2002). Course and outcome of hepatitis C. Hepatology 36,
S21–S29.
Jackson, R.J., and Standart, N. (2007). How do microRNAs regulate gene
expression? Sci. STKE 2007, re1.
Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M., and Sarnow, P. (2005).
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
Science 309, 1577–1581.
Jopling, C.L., Norman, K.L., and Sarnow, P. (2006). Positive and negative
modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Cold Spring Harb. Symp. Quant. Biol. 71, 369–376.
Kru¨tzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan,
M., and Stoffel, M. (2005). Silencing of microRNAs in vivo with ‘‘antagomirs’’.
Nature 438, 685–689.
Lewis, B.P., Burge, C.B., and Bartel, D.P. (2005). Conserved seed pairing,
often flanked by adenosines, indicates that thousands of human genes are
microRNA targets. Cell 120, 15–20.
Lytle, J.R., Yario, T.A., and Steitz, J.A. (2007). Target mRNAs are repressed as
efficiently by microRNA-binding sites in the 50 UTR as in the 30 UTR. Proc. Natl.
Acad. Sci. USA 104, 9667–9672.
Nilsen, T.W. (2007). Mechanisms of microRNA-mediated gene regulation in
animal cells. Trends Genet. 23, 243–249.
Randall, G., Panis, M., Cooper, J.D., Tellinghuisen, T.L., Sukhodolets, K.E.,
Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S., Lindenbach, B.D., et al.
(2007). Cellular cofactors affecting hepatitis C virus infection and replication.
Proc. Natl. Acad. Sci. USA 104, 12884–12889.
Saetrom, P., Heale, B.S., Snove, O., Jr., Aagaard, L., Alluin, J., and Rossi, J.J.
(2007). Distance constraints between microRNA target sites dictate efficacy
and cooperativity. Nucleic Acids Res. 35, 2333–2342.
Xie, X., Lu, J., Kulbokas, E.J., Golub, T.R., Mootha, V., Lindblad-Toh, K.,
Lander, E.S., and Kellis, M. (2005). Systematic discovery of regulatory motifs
in human promoters and 30 UTRs by comparison of several mammals. Nature
434, 338–345.
Yi, M., and Lemon, S.M. (2004). Adaptive mutations producing efficient repli-
cation of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J. Virol.
78, 7904–7915.
Yi, M., Villanueva, R.A., Thomas, D.L., Wakita, T., and Lemon, S.M. (2006).
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in
cultured human hepatoma cells. Proc. Natl. Acad. Sci. USA 103, 2310–2315.Cell Host & Microbe 4, 77–85, July 17, 2008 ª2008 Elsevier Inc. 85
